Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brendan M Boyle

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Biorxiv : the Preprint Server for Biology|August 12, 2025
Model-informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's DiseaseKei Irie, Phillip Minar, Jack Reifenberg, et al.
Clinical Pharmacology and Therapeutics|November 5, 2025
Model-Informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's DiseaseKei Irie, Phillip Minar, Jack Reifenberg, et al.
World Journal of Gastroenterology|August 2, 2014
Routine use of thiopurines in maintaining remission in pediatric Crohn's diseaseBrendan M Boyle, Michael D Kappelman, Richard B Colletti, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 11, 2014
Incidence, pattern, and etiology of elevated liver enzymes in pediatric inflammatory bowel diseaseAntoinette J Pusateri, Sandra C Kim, Jennifer L Dotson, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 2, 2020
Predicting Suboptimal Transitions in Adolescents With Inflammatory Bowel DiseaseHaley Pearlstein, Josh Bricker, Hilary K Michel, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 24, 2023
Biosimilars for Pediatric Patients With Inflammatory Bowel Disease: Pediatric Gastroenterology Clinical Practice SurveyRoss M Maltz, Madeline G McClinchie, Brendan M Boyle, et al.
Inflammatory Bowel Diseases|September 18, 2020
Achieving Target Infliximab Drug Concentrations Improves Blood and Fecal Neutrophil Biomarkers in Crohn's DiseaseRuben J Colman, Yi-Ting Tsai, Kimberly Jackson, et al.
Pediatrics|March 14, 2012
Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel diseaseWallace V Crandall, Peter A Margolis, Michael D Kappelman, et al.
Crohn'S & Colitis 360|February 13, 2023
Similar Long-Term Outcomes in Children Presenting With Abscess vs Phlegmon at Diagnosis of Crohn DiseaseAndrew W Fondell, Maua H Mosha, Ross M Maltz, et al.
Journal of Pediatric Gastroenterology and Nutrition|August 26, 2021
Early Change in Fecal Calprotectin Predicts One-Year Outcome in Children Newly Diagnosed With Ulcerative ColitisChenthan Krishnakumar, Ashwin N Ananthakrishnan, Brendan M Boyle, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Biorxiv : the Preprint Server for Biology|August 12, 2025
Model-informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's DiseaseKei Irie, Phillip Minar, Jack Reifenberg, et al.
Clinical Pharmacology and Therapeutics|November 5, 2025
Model-Informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's DiseaseKei Irie, Phillip Minar, Jack Reifenberg, et al.
World Journal of Gastroenterology|August 2, 2014
Routine use of thiopurines in maintaining remission in pediatric Crohn's diseaseBrendan M Boyle, Michael D Kappelman, Richard B Colletti, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 11, 2014
Incidence, pattern, and etiology of elevated liver enzymes in pediatric inflammatory bowel diseaseAntoinette J Pusateri, Sandra C Kim, Jennifer L Dotson, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 2, 2020
Predicting Suboptimal Transitions in Adolescents With Inflammatory Bowel DiseaseHaley Pearlstein, Josh Bricker, Hilary K Michel, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 24, 2023
Biosimilars for Pediatric Patients With Inflammatory Bowel Disease: Pediatric Gastroenterology Clinical Practice SurveyRoss M Maltz, Madeline G McClinchie, Brendan M Boyle, et al.
Inflammatory Bowel Diseases|September 18, 2020
Achieving Target Infliximab Drug Concentrations Improves Blood and Fecal Neutrophil Biomarkers in Crohn's DiseaseRuben J Colman, Yi-Ting Tsai, Kimberly Jackson, et al.
Pediatrics|March 14, 2012
Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel diseaseWallace V Crandall, Peter A Margolis, Michael D Kappelman, et al.
Crohn'S & Colitis 360|February 13, 2023
Similar Long-Term Outcomes in Children Presenting With Abscess vs Phlegmon at Diagnosis of Crohn DiseaseAndrew W Fondell, Maua H Mosha, Ross M Maltz, et al.
Journal of Pediatric Gastroenterology and Nutrition|August 26, 2021
Early Change in Fecal Calprotectin Predicts One-Year Outcome in Children Newly Diagnosed With Ulcerative ColitisChenthan Krishnakumar, Ashwin N Ananthakrishnan, Brendan M Boyle, et al.
Pageof 3